Literature DB >> 9003773

Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis.

R U Jänicke1, P A Walker, X Y Lin, A G Porter.   

Abstract

Interleukin 1beta-converting enzyme-like (ICE-like) proteases are important mediators of apoptosis in diverse cell types and organisms. However, the role of these proteases in apoptosis cannot be satisfactorily explained on the basis of the physiological functions of their known substrates. Here we show that the C-terminal 42 amino acid peptide of the retinoblastoma (Rb) protein, an important cell cycle regulator with a known anti-apoptotic function, is specifically cleaved off by an ICE-like protease in tumour necrosis factor (TNF)- and staurosporine-induced apoptosis. Cleavage of Rb induced by TNF was blocked in vivo and in vitro by two specific inhibitors of ICE-like proteases, and in vitro by a point mutation (Asp886 to Ala) within the ICE-like protease cleavage site of Rb, (883)DEAD(886). An antibody raised against the C-terminal 15 amino acid peptide of Rb recognized the full-length but not the cleaved form of Rb. The extent of Rb cleavage correlated directly with TNF-induced apoptosis in all tumour cell lines examined. Cleaved Rb bound cyclin D3 and inhibited the transcriptional activity of E2F-1, but failed to bind to the regulatory protein MDM2, which has been implicated in apoptosis. As Rb suppresses cell death and its C-terminus has important regulatory functions, our results suggest that Rb cleavage is an important event in apoptosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003773      PMCID: PMC452523     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  58 in total

1.  Identification of a growth suppression domain within the retinoblastoma gene product.

Authors:  X Q Qin; T Chittenden; D M Livingston; W G Kaelin
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

Review 2.  Protease activation during apoptosis: death by a thousand cuts?

Authors:  S J Martin; D R Green
Journal:  Cell       Date:  1995-08-11       Impact factor: 41.582

Review 3.  The retinoblastoma tumor suppressor protein.

Authors:  J Y Wang; E S Knudsen; P J Welch
Journal:  Adv Cancer Res       Date:  1994       Impact factor: 6.242

4.  A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor.

Authors:  P Singh; J Coe; W Hong
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

5.  Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway.

Authors:  W D Jarvis; R N Kolesnick; F A Fornari; R S Traylor; D A Gewirtz; S Grant
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

6.  Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

Authors:  Z Q Wang; B Auer; L Stingl; H Berghammer; D Haidacher; M Schweiger; E F Wagner
Journal:  Genes Dev       Date:  1995-03-01       Impact factor: 11.361

7.  Participation of cyclin A in Myc-induced apoptosis.

Authors:  A T Hoang; K J Cohen; J F Barrett; D A Bergstrom; C V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

8.  Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis.

Authors:  X Wang; N G Zelenski; J Yang; J Sakai; M S Brown; J L Goldstein
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

Review 9.  ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis.

Authors:  D W Nicholson
Journal:  Nat Biotechnol       Date:  1996-03       Impact factor: 54.908

10.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

Authors:  J Yuan; S Shaham; S Ledoux; H M Ellis; H R Horvitz
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  51 in total

1.  Apoptosis induced by the nuclear death domain protein p84N5 is inhibited by association with Rb protein.

Authors:  J Doostzadeh-Cizeron; R Evans; S Yin; D W Goodrich
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

Review 2.  Death and destruction of activated T lymphocytes.

Authors:  I N Crispe
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.

Authors:  S Wang; N Nath; A Minden; S Chellappan
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

4.  Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.

Authors:  S L Gonzalez; M Stremlau; X He; J R Basile; K Münger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E.

Authors:  J L Nargi; R R Ratan; D E Griffin
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

6.  Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system.

Authors:  D MacPherson; J Sage; D Crowley; A Trumpp; R T Bronson; T Jacks
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

7.  Cleavage of rabaptin-5 blocks endosome fusion during apoptosis.

Authors:  S C Cosulich; H Horiuchi; M Zerial; P R Clarke; P G Woodman
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

8.  Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

Authors:  R Bremner; D C Du; M J Connolly-Wilson; P Bridge; K F Ahmad; H Mostachfi; D Rushlow; J M Dunn; B L Gallie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

9.  Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation.

Authors:  F J Piedrafita; M Pfahl
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

10.  XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer.

Authors:  Yan Cheng; Michael P Holloway; Kevin Nguyen; Dilara McCauley; Yosef Landesman; Michael G Kauffman; Sharon Shacham; Rachel A Altura
Journal:  Mol Cancer Ther       Date:  2014-01-15       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.